Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Antipsychotics plus Levothyroxine Sodium with placebo for people with Schizophrenia or Avolition. Participants receive Antipsychotics plus Levothyroxine Sodium or placebo and complete study visits and assessments.
This study is looking at whether Active rTMS can help people with Schizophrenia. Participants take part in Active rTMS and complete follow-up assessments.
This study is comparing Rivastigmine Transdermal System with placebo for people with Hallucinations, Auditory or Psychosis. Participants receive Rivastigmine Transdermal System or placebo and complete study visits and assessments.
This study is comparing High-intensity transcranial alternating current stimulation (Hi-tACS) with control group for people with Schizophrenia, Negative Type, or Transcranial Alternating Current Stimulation. Participants receive High-intensity transcranial alternating current stimulation (Hi-tACS) or control group and complete study visits and assessments.
This observational study is following people with Psychosis or Cannabis Use to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is comparing Ziprasidone with placebo for people with Schizophrenia. Participants receive Ziprasidone or placebo and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Psychosis. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Taking part may give some people access to ACP-204, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Taking part may give some people access to KarXT, but direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Lewy Body Dementia Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at care and outcomes for people with Psychosis Associated With Alzheimer's Disease. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing MT1988 Low Dose with placebo for people with Clinical High Risk for Psychosis. Participants receive MT1988 Low Dose or placebo and complete study visits and assessments.
This observational study is following people with Alzheimer's Disease Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Behavioral Activation for First Episode Psychosis can help people with Engagement or First Episode Psychosis. Participants receive Behavioral Activation for First Episode Psychosis or usual care and complete study visits and assessments.
This observational study is following people with Focal Epilepsy With and Without Secondary Generalization or Psychotic Symptoms to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Methamphetamine Use Disorder or Methamphetamine Induced Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Induced Psychosis or Cannabis Use to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This observational study is following people with Methamphetamine Induced Psychosis to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This study is looking at care and outcomes for people with Alzheimer's Disease Psychosis. Taking part may give some people access to ACP-204, but direct benefit is not guaranteed.
This study is looking at whether Financial Incentive and Text-Messages can help people with First-Episode Psychosis. Participants take part in Financial Incentive and Text-Messages and complete follow-up assessments.
This study is looking at whether cognitive behavioural therapy can help people with Clinical High-Risk or Psychological. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at whether On Track for Wellness can help people with Sleep, Physical Activity, or First Episode Psychosis. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
This study is looking at evaluate the feasibility and effectiveness of telehealth interventions for individuals at clinical high risk for psychosis (CHR). Participants take part in the program and complete follow-up questionnaires or assessments.
This study is comparing ITI-1284 with placebo for people with Psychosis Associated With Alzheimer's Disease. Participants receive ITI-1284 or placebo and complete study visits and assessments.